Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib‐resistant lung adenocarcinoma cells

Jie Ni(Jiangsu Cancer Hospital), Jifeng Feng(Nanjing Medical University)
Cancer Medicine
March 23, 2018
Cited by 19


Related Papers